Artwork

Danish Diabetes and Endocrine Academy, Danish Diabetes, and Endocrine Academy에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Danish Diabetes and Endocrine Academy, Danish Diabetes, and Endocrine Academy 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
Player FM -팟 캐스트 앱
Player FM 앱으로 오프라인으로 전환하세요!

Should We Be Rethinking the Scientific Publication?

28:09
 
공유
 

Manage episode 377679332 series 3310882
Danish Diabetes and Endocrine Academy, Danish Diabetes, and Endocrine Academy에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Danish Diabetes and Endocrine Academy, Danish Diabetes, and Endocrine Academy 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Is the scientific publication, as we know it, dead?

This was the central question behind the theme for this year’s DDEA Postdoc Summit Challenge.
Researchers learn early on to think in terms of impact factors and citation metrics. In an overflowing ocean of scientific content, the pressure to make your publications matter seems higher than ever. Yet according to recent studies, the impact of Danish research has been on an overall steady decline, and papers are generally becoming less disruptive over time.
But what is scientific impact and how is it measured? And is it time to look at alternatives to a practice that has changed very little in the last 100 years?
In this episode, we hand over the microphone to a postdoc, Christopher Lewis, who landed an interview with none other than the Senior Vice President of Impact at the Novo Nordisk Foundation, Thomas Alslev Christensen.
Listen, as an early-career researcher addresses the burning questions about the direction of scientific impact to one with a job specifically tied to this subject at a highly influential research institution.
The Novo Nordisk Foundation:

The Novo Nordisk Foundation (NNF) is a Danish foundation supporting the business and research activities of the Novo Group’s companies (Novo Nordisk A/S and Novozymes A/S), providing support for scientific, humanitarian, and social purposes. In 2022, the NNF granted DKK 7.464 billion DKK for a total of 695 new initiatives. The DDEA is funded by the NNF with a five-year grant of 194 million DKK.
Guests

  • Thomas Alslev Christensen, Senior Vice President of Impact at the Novo Nordisk Foundation

Host

  • Christopher Lewis, Postdoc, University of Copenhagen

Produced by

Gretchen Repasky, Education & Networking Manager, Danish Diabetes and Endocrine Academy

Published by

Danish Diabetes and Endocrine Academy

Editor

Nikolai Rosler – Rosler Productions

You can find additional information about our podcasts on Podcasts | Danish Diabetes and Endocrine Academy (ddeacademy.dk)

  continue reading

19 에피소드

Artwork
icon공유
 
Manage episode 377679332 series 3310882
Danish Diabetes and Endocrine Academy, Danish Diabetes, and Endocrine Academy에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Danish Diabetes and Endocrine Academy, Danish Diabetes, and Endocrine Academy 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

Is the scientific publication, as we know it, dead?

This was the central question behind the theme for this year’s DDEA Postdoc Summit Challenge.
Researchers learn early on to think in terms of impact factors and citation metrics. In an overflowing ocean of scientific content, the pressure to make your publications matter seems higher than ever. Yet according to recent studies, the impact of Danish research has been on an overall steady decline, and papers are generally becoming less disruptive over time.
But what is scientific impact and how is it measured? And is it time to look at alternatives to a practice that has changed very little in the last 100 years?
In this episode, we hand over the microphone to a postdoc, Christopher Lewis, who landed an interview with none other than the Senior Vice President of Impact at the Novo Nordisk Foundation, Thomas Alslev Christensen.
Listen, as an early-career researcher addresses the burning questions about the direction of scientific impact to one with a job specifically tied to this subject at a highly influential research institution.
The Novo Nordisk Foundation:

The Novo Nordisk Foundation (NNF) is a Danish foundation supporting the business and research activities of the Novo Group’s companies (Novo Nordisk A/S and Novozymes A/S), providing support for scientific, humanitarian, and social purposes. In 2022, the NNF granted DKK 7.464 billion DKK for a total of 695 new initiatives. The DDEA is funded by the NNF with a five-year grant of 194 million DKK.
Guests

  • Thomas Alslev Christensen, Senior Vice President of Impact at the Novo Nordisk Foundation

Host

  • Christopher Lewis, Postdoc, University of Copenhagen

Produced by

Gretchen Repasky, Education & Networking Manager, Danish Diabetes and Endocrine Academy

Published by

Danish Diabetes and Endocrine Academy

Editor

Nikolai Rosler – Rosler Productions

You can find additional information about our podcasts on Podcasts | Danish Diabetes and Endocrine Academy (ddeacademy.dk)

  continue reading

19 에피소드

모든 에피소드

×
 
Loading …

플레이어 FM에 오신것을 환영합니다!

플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.

 

빠른 참조 가이드

탐색하는 동안 이 프로그램을 들어보세요.
재생